| __timestamp | Alpine Immune Sciences, Inc. | Amgen Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2287709 | 4699000000 |
| Thursday, January 1, 2015 | 6844000 | 4846000000 |
| Friday, January 1, 2016 | 8586000 | 5062000000 |
| Sunday, January 1, 2017 | 6079000 | 4870000000 |
| Monday, January 1, 2018 | 8362000 | 5332000000 |
| Tuesday, January 1, 2019 | 9467000 | 5150000000 |
| Wednesday, January 1, 2020 | 10899000 | 5730000000 |
| Friday, January 1, 2021 | 14560000 | 5368000000 |
| Saturday, January 1, 2022 | 17968000 | 5414000000 |
| Sunday, January 1, 2023 | 22222000 | 6179000000 |
| Monday, January 1, 2024 | 7096000000 |
Unveiling the hidden dimensions of data
In the competitive landscape of biotechnology, understanding spending patterns is crucial. Over the past decade, Amgen Inc. and Alpine Immune Sciences, Inc. have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses. Amgen, a giant in the industry, consistently allocated a significant portion of its budget to SG&A, with a peak in 2023, reaching nearly 6.2 billion dollars. This represents a steady increase of about 31% from 2014. In contrast, Alpine Immune Sciences, a smaller player, exhibited a more dynamic growth in SG&A spending, surging by approximately 872% from 2014 to 2023. This rapid increase reflects Alpine's aggressive expansion strategy. The data highlights the contrasting approaches of a well-established leader and an emerging innovator in managing operational costs, offering insights into their strategic priorities.
Selling, General, and Administrative Costs: Amgen Inc. vs Sanofi
Cost Management Insights: SG&A Expenses for Amgen Inc. and Teva Pharmaceutical Industries Limited
Comparing SG&A Expenses: Amgen Inc. vs Pharming Group N.V. Trends and Insights
Amgen Inc. vs Apellis Pharmaceuticals, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Amgen Inc. and Perrigo Company plc
Amgen Inc. vs Vericel Corporation: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Amgen Inc. and Novavax, Inc.
Selling, General, and Administrative Costs: Summit Therapeutics Inc. vs Alpine Immune Sciences, Inc.
Comparing SG&A Expenses: Alkermes plc vs Alpine Immune Sciences, Inc. Trends and Insights
Opthea Limited vs Alpine Immune Sciences, Inc.: SG&A Expense Trends
Alpine Immune Sciences, Inc. vs Bausch Health Companies Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Alpine Immune Sciences, Inc. vs Viridian Therapeutics, Inc. Trends and Insights